SOPHiA GENETICS SA Net Cash Flow 2020-2025 | SOPH
SOPHiA GENETICS SA net cash flow from 2020 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
| SOPHiA GENETICS SA Annual Net Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $-43 |
| 2023 | $-38 |
| 2022 | $-32 |
| 2021 | $118 |
| 2020 | $57 |
| 2019 | $-36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.224B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.502B | 54.47 |
| Doximity (DOCS) | United States | $12.809B | 56.99 |
| Tempus AI (TEM) | United States | $12.797B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.972B | 81.70 |
| IRhythm Technologies (IRTC) | United States | $5.509B | 0.00 |
| Hinge Health (HNGE) | United States | $4.528B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.705B | 39.76 |
| Privia Health (PRVA) | United States | $2.677B | 198.27 |
| Heartflow (HTFL) | $2.609B | 0.00 | |
| Phreesia (PHR) | United States | $1.937B | 0.00 |
| 10x Genomics (TXG) | United States | $1.778B | 0.00 |
| Enovis (ENOV) | United States | $1.749B | 9.24 |
| Omnicell (OMCL) | United States | $1.529B | 29.45 |
| Schrodinger (SDGR) | United States | $1.454B | 0.00 |
| Azenta (AZTA) | United States | $1.372B | 59.84 |
| Clover Health Investments (CLOV) | United States | $1.348B | 0.00 |
| Claritev (CTEV) | United States | $1.174B | 0.00 |
| Evolent Health (EVH) | United States | $1.133B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.674B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.410B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.60 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.164B | 0.00 |
| CareCloud (CCLD) | United States | $0.160B | 7.27 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.082B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |